TY - JOUR
T1 - Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy
T2 - Results of a combined molecular and histopathologic mapping study
AU - Heck, Matthias M.
AU - Retz, Margitta
AU - Bandur, Miriam
AU - Souchay, Marc
AU - Vitzthum, Elisabeth
AU - Weirich, Gregor
AU - Mollenhauer, Martin
AU - Schuster, Tibor
AU - Autenrieth, Michael
AU - Kübler, Hubert
AU - Maurer, Tobias
AU - Thalgott, Mark
AU - Herkommer, Kathleen
AU - Gschwend, Jürgen E.
AU - Nawroth, Roman
N1 - Funding Information:
We confirmed the PCR-based technique as a reliable and more sensitive method than standard histopathology for the detection of small-volume LN metastases of PCa patients. In our study population, standard histopathology misclassified more than a fourth of patients as LN negative. We demonstrated that dissection of common iliac vessels, at least up to the ureteral crossing, as part of the ePLND is required to optimise nodal staging and to remove LNs potentially harbouring metastases. A larger patient cohort with long-term follow-up is required to determine the clinical impact of molecular-detected metastases in the ePLND field on biochemical recurrence and survival in PCa patients. Author contributions: Matthias M. Heck had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Heck, Retz, Nawroth, Gschwend. Acquisition of data: Heck, Bandur, Souchay, Vitzthum, Kübler, Autenrieth, Maurer, Gschwend, Thalgott, Herkommer, Weirich, Mollenhauer. Analysis and interpretation of data: Heck, Nawroth. Drafting of the manuscript: Heck, Nawroth. Critical revision of the manuscript for important intellectual content: Heck, Retz, Nawroth. Statistical analysis: Heck, Schuster. Obtaining funding: Heck, Gschwend, Retz, Nawroth. Administrative, technical, or material support: Heck, Nawroth. Supervision: Gschwend, Retz, Nawroth. Other (specify): None. Financial disclosures: Matthias M. Heck certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. Funding/Support and role of the sponsor: Data collection and results were facilitated by the support of the German Wilhelm-Sander Foundation and the Reinhard-Nagel Foundation by the German Association of Urology.
PY - 2014/8
Y1 - 2014/8
N2 - Background To determine the anatomic extent of pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients at the time of radical prostatectomy (RP), knowledge about the topography of lymph node (LN) metastases is required. Objective Because small-volume LN metastases may be missed by standard histopathologic examination, we performed an anatomic mapping study combining molecular and histopathologic LN examination in PCa patients treated with RP and extended PLND (ePLND). Design, setting, and participants A total of 52 patients with intermediate- (n = 15) and high-risk (n = 37) PCa underwent RP and ePLND without neoadjuvant treatment. ePLND included dissection of the obturator fossa and the external, internal, and common iliac vessels. Outcome measurements and statistical analysis LNs ≥3 mm in diameter were analysed by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) for prostate-specific antigen (PSA) expression and by standard histopathology. Topography of positive LNs was determined descriptively. Results and limitations Of 1469 dissected LNs (median: 27 LNs per patient), 1186 LNs were ≥3 mm. Molecular LN analysis was positive in 127 LNs of 27 patients (52%) including 32 LNs of 12 patients (23%) with histopathologic positive LNs. Molecular examination was negative in 3 of 35 histopathologic positive LNs (9%). Combining both molecular and histopathologic findings, positive LNs were located in the standard PLND field defined by obturator fossa and external iliac vessels in 71%, along the internal iliac vessels in 16%, and along the common iliac vessels in 13%. Of LN-positive patients, 63% had LN metastases outside the standard PLND field. The internal iliac field was involved in 48% and the common iliac field in 37% of node-positive patients. Notably, internal and common iliac vessels were the only positive regions in 7% and 11% of node-positive patients, respectively. A limitation is the small number of patients included. Conclusions These findings underline the enhanced sensitivity of qRT-PCR in comparison with standard histopathology for detection of small-volume LN metastases in PCa patients. Our results support an ePLND including the common iliac vessels, at least up to the ureteral crossing, to optimise nodal staging and to remove LNs potentially harbouring metastases.
AB - Background To determine the anatomic extent of pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients at the time of radical prostatectomy (RP), knowledge about the topography of lymph node (LN) metastases is required. Objective Because small-volume LN metastases may be missed by standard histopathologic examination, we performed an anatomic mapping study combining molecular and histopathologic LN examination in PCa patients treated with RP and extended PLND (ePLND). Design, setting, and participants A total of 52 patients with intermediate- (n = 15) and high-risk (n = 37) PCa underwent RP and ePLND without neoadjuvant treatment. ePLND included dissection of the obturator fossa and the external, internal, and common iliac vessels. Outcome measurements and statistical analysis LNs ≥3 mm in diameter were analysed by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) for prostate-specific antigen (PSA) expression and by standard histopathology. Topography of positive LNs was determined descriptively. Results and limitations Of 1469 dissected LNs (median: 27 LNs per patient), 1186 LNs were ≥3 mm. Molecular LN analysis was positive in 127 LNs of 27 patients (52%) including 32 LNs of 12 patients (23%) with histopathologic positive LNs. Molecular examination was negative in 3 of 35 histopathologic positive LNs (9%). Combining both molecular and histopathologic findings, positive LNs were located in the standard PLND field defined by obturator fossa and external iliac vessels in 71%, along the internal iliac vessels in 16%, and along the common iliac vessels in 13%. Of LN-positive patients, 63% had LN metastases outside the standard PLND field. The internal iliac field was involved in 48% and the common iliac field in 37% of node-positive patients. Notably, internal and common iliac vessels were the only positive regions in 7% and 11% of node-positive patients, respectively. A limitation is the small number of patients included. Conclusions These findings underline the enhanced sensitivity of qRT-PCR in comparison with standard histopathology for detection of small-volume LN metastases in PCa patients. Our results support an ePLND including the common iliac vessels, at least up to the ureteral crossing, to optimise nodal staging and to remove LNs potentially harbouring metastases.
KW - Common iliac vessels
KW - Extended pelvic lymph node dissection
KW - Histopathology
KW - Lymph node metastasis
KW - Micrometastasis
KW - Polymerase chain reaction
KW - Prostate cancer
KW - Radical prostatectomy
KW - Staging
UR - http://www.scopus.com/inward/record.url?scp=84904051469&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2013.02.007
DO - 10.1016/j.eururo.2013.02.007
M3 - Article
C2 - 23465520
AN - SCOPUS:84904051469
SN - 0302-2838
VL - 66
SP - 222
EP - 229
JO - European Urology
JF - European Urology
IS - 2
ER -